Evidence map›Paper›PMID 34820597›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2021

Outcomes of a Comprehensive Pain Rehabilitation Program for Patients With Fibromyalgia.

Erica Engelberg-Cook, Danqing Hu, Svetlana Kurklinsky, Anwar Mack, Christopher D Sletten, Wenchun Qu, Michael D Osborne

Open access · goldAbstract read
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Validation and cross-cultural adaptation of an Arabic version of the chronic pain self-efficacy scale.Hong Kong physiotherapy journal : official publication of the Hong Kong Physiotherapy Association Limited = Wu li chih liao · 2025
    Article
  3. Article
  4. Do FIQR Severity Categories and Symptoms, Differentiate Between Continuous, Intermittent and Non-Opioid Users in the Treatment of Fibromyalgia?Pain management nursing : official journal of the American Society of Pain Management Nurses · 2024
    Observational
  5. Article
  6. Neurophenotypes of COVID-19: Risk factors and recovery outcomes.Brain, behavior, & immunity - health · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Erica Engelberg-CookDepartment of Pain Medicine, Mayo Clinic, Jacksonville, FL.
Danqing HuMayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Jacksonville, FL.
Svetlana KurklinskyCenter for Health Sciences, Oklahoma State University, Tulsa, OK.
Anwar MackDepartment of Pain Medicine, Mayo Clinic, Jacksonville, FL.
Christopher D SlettenDepartment of Pain Medicine, Mayo Clinic, Jacksonville, FL.
Wenchun QuDepartment of Pain Medicine, Mayo Clinic, Jacksonville, FL.
Michael D OsborneDepartment of Pain Medicine, Mayo Clinic, Jacksonville, FL.
Mayo Clinic in Florida · USJacksonville College · USOklahoma State University Center for Health Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze opioid intake interference with psychological, well-being, and functional outcomes and medication tapering in patients with fibromyalgia admitted to the Mayo Clinic Pain Rehabilitation Program (MCPRP) in Florida. PATIENTS AND

methodsA retrospective study on MCPRP outcomes was conducted. We reviewed the health records of 150 patients with fibromyalgia who participated in the program from May 1, 2014, to May 1, 2015. All patients were asked to fill out a survey at admission to and dismissal from the program. Surveys contained questions from the numeric pain score, Multidimensional Pain Inventory (perceived life control and interference of pain subscales), Center for Epidemiological Studies-Depression Scale, Pain Catastrophizing Scale, 36-Item Short-Form Health Status Survey (general health perceptions subscale), and Pain Self-Efficacy Questionnaire. A medical record review identified categories and number of medications at program admission and dismissal. Patients were divided in 2 groups: those whose concomitant medication did not include opioids at admission (no opioids group) and those whose concomitant medication included opioids at admission (opioids group).

resultsBy dismissal from the MCPRP, patients with fibromyalgia in the no opioids group had a significant (

conclusionBenefit of the comprehensive pain rehabilitation program in patients with fibromyalgia was indicated by clinical improvements in pain severity, physical and emotional health, and functional capacity while successfully tapering medication. Opioid intake at admission may modify the program outcomes.

Indexed as

CESD, Center for Epidemiological Studies–Depression ScaleCSS, central sensitization syndromeFM, fibromyalgiaMCPRP, Mayo Clinic Comprehensive Pain Rehabilitation ProgramMPI, Multidimensional Pain InventoryNO, no opioids on admissionNSAID, nonsteroidal anti-inflammatory drugOME, oral morphine equivalentOP, opioids on admissionPCS, Pain Catastrophizing ScalePSEQ, Pain Self-Efficacy QuestionnaireSF-36, 36-Item Short-Form Health Status SurveySS, Symptom Severity ScaleWPI, Widespread Pain Index

Identifiers

PMID34820597
PMCPMC8601967
OpenAlexW3213723015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.